Does Your Acute Migraine Medicine Work Well Enough? What a 404-Patient Study Found

In 404 people with migraine, those whose attack medicine worked poorly had about three times the disability of people with the same number of headache days whose medicine worked well.

On this page · 8 sections
  1. Why This Question Matters
  2. How the Study Worked
  3. What the Study Found
  4. How Acute Response Compared With Other Factors
  5. Limitations to Keep in Mind
  6. What This Means for You
  7. Key Takeaways
  8. References

Why This Question Matters

When clinicians decide how aggressively to treat migraine, the first number they usually reach for is how many headache days you have each month. That number decides whether you fall in the episodic or chronic range (our chronic migraine calculator walks through the cutoffs) and whether prevention should be offered.

A second question gets less attention: when a migraine attack does start, how well does the medicine you take for it work? Two people can both have 3 headache days a month. One takes a pill and is back at work in an hour. The other takes the same kind of pill, waits, takes another, and loses the rest of the day.

A new study in Headache from a tertiary headache center in Chongqing, China, set out to measure how much that second question shapes disability. The researchers enrolled 404 consecutive patients with migraine and looked at headache frequency and acute treatment response side by side.

How the Study Worked

This was a cross-sectional study, meaning everyone was assessed once, at a single point in time. Each patient filled out three questionnaires.

  • Acute treatment response: the 12-item Chinese version of the Migraine Treatment Optimization Questionnaire (mTOQ-C12). It asks how well your usual attack medicine works and scores from 0 to 12. A score of 9 or lower counted as a suboptimal response.
  • Disability: the Migraine Disability Assessment (MIDAS), which counts days of missed or reduced work, school, household and social activity. Higher scores mean more disability. You can score yourself with our MIDAS calculator.
  • Quality of life: the Migraine-Specific Quality of Life Questionnaire, version 2.1. Higher scores mean better quality of life.

The team then split patients into four groups by crossing two yes-or-no questions: 8 or more headache days a month versus fewer than 8, and adequate versus suboptimal acute treatment response. They also adjusted for age, sex, headache features and psychological measures, including depression and anxiety scores.

How MIDAS Scores Are Usually Graded

MIDAS scores are commonly sorted into four grades: 0 to 5 is little or no disability, 6 to 10 is mild, 11 to 20 is moderate, and 21 or higher is severe. Keep these in mind when reading the numbers below.

What the Study Found

404
Patients
Consecutive adults with migraine at one tertiary headache center
12 vs 4
Median MIDAS Score
Poor vs adequate acute responders, both with a median of 3 headache days a month
3 vs 15
Headache Days a Month
Yet poor responders at 3 days had adjusted disability similar to good responders at 15 days
4 to 20.3
Range of Median MIDAS
Median disability scores across the four frequency and response groups

The four groups differed clearly in both disability and quality of life. Median MIDAS scores ranged from 4.0 in the best-off group to 20.3 in the worst-off group, and median quality-of-life scores ranged from 68.7 to 80.7.

The sharpest contrast came among people with fewer than 8 headache days a month. Both the adequate and the suboptimal responders in this low-frequency range had a median of 3 headache days a month. The suboptimal responders had a median MIDAS score of 12.0, in the moderate range. The adequate responders had a median of 4.0, in the little-or-no-disability range.

The researchers then compared low-frequency suboptimal responders with high-frequency adequate responders. After adjusting for other factors, the two groups had similar disability scores, differing by about 1 MIDAS point, even though their median headache frequency was 3 versus 15 days a month. A formal equivalence test supported the idea that the two groups were within 5 points of each other.

Comparison Headache Days a Month (Median) Disability Result
Low frequency, adequate response 3 Median MIDAS 4.0 (little or no disability)
Low frequency, suboptimal response 3 Median MIDAS 12.0 (moderate disability)
Low frequency suboptimal vs high frequency adequate 3 vs 15 Adjusted difference of about 1 MIDAS point, judged equivalent within a 5-point margin
All four groups Varied Median MIDAS from 4.0 to 20.3; quality of life from 68.7 to 80.7

One exploratory result pointed the same way. Among low-frequency patients, each extra headache day was tied to more disability in suboptimal responders than in adequate responders. The difference between the two groups was not statistically significant, so this part is a lead for future studies, not a finding.

How Acute Response Compared With Other Factors

Acute treatment response stayed linked to disability after an adjusted analysis that accounted for demographics, headache features and psychological measures. Better mTOQ scores went with lower disability.

It was not the biggest factor. Depression symptoms, measured with the PHQ-9 questionnaire, contributed more to disability than acute treatment response did. Acute response contributed about as much as monthly headache days. A machine learning analysis ranked the factors in a similar order, with depression symptoms first.

That ordering fits a long line of research tying mood and migraine together. If depression is part of your picture, our overview of migraine and depression covers the shared biology and treatments that can help both.

Key Point

In this study, how well attack medicine worked was about as strongly tied to disability as how often attacks happened. Depression symptoms were tied to disability more strongly than either.

Limitations to Keep in Mind

The authors and the study design point to several limits.

  • One snapshot in time. Because everyone was measured once, the study shows an association, not cause and effect. It cannot show that improving acute treatment would lower disability. See association vs causation.
  • The arrow could point both ways. People who are more disabled by migraine may also rate their medicine more harshly. This is called reverse causation.
  • One center. All patients came from a single tertiary headache center in China, where patients tend to have harder-to-treat migraine. The results may not carry over to primary care or other countries. See generalizability.
  • Questionnaire-based. Treatment response and disability were both self-reported, and the mTOQ-C12 is a Chinese-language version of the questionnaire.
  • Simple cutoffs. Splitting patients at 8 headache days and an mTOQ score of 9 makes the groups easy to compare but hides variation inside each group.

What This Means for You

The practical message is to judge your attack treatment on its own, not only by how many attacks you have. A few questions can help you check whether your current approach is working:

  • Within about 2 hours of taking it, are you pain-free or close to it most of the time?
  • Does the relief last, or does the headache come back later the same day?
  • Can you get back to work, school or family life after taking it?
  • Are the side effects tolerable?
  • Do you feel confident planning your day around attacks?

If several answers are no, that is a reason to talk with your clinician even if your attacks are not frequent. Options commonly discussed include taking medicine earlier in the attack, adjusting the dose, combining medicines, switching to a different drug class, or switching to a nasal spray or injection when nausea or vomiting makes pills unreliable. Our guide to acute migraine treatment covers the main classes, and our piece on choosing medicines by administration route explains how the route changes speed and side effects.

Response can also change from one attack to the next. In an earlier study we covered, rimegepant (Nurtec ODT) gave pain freedom in 45% of attacks, and most people did not respond the same way every time. Judging a medicine over several attacks gives a fairer picture than judging it on one.

Poorly working attack medicine can also lead to taking more doses, which raises the risk of medication overuse headache. Our medication overuse headache checker compares your medicine days with the usual limits. Before your next visit, the migraine appointment summary sheet has space to record how each attack medicine has worked for you.

Key Takeaways

Key Takeaways
  • In 404 people with migraine, those whose attack medicine worked poorly had higher disability than those whose medicine worked well.
  • Among people with a median of 3 headache days a month, poor responders had a median MIDAS score of 12 versus 4 for good responders.
  • Poor responders with 3 headache days a month had adjusted disability similar to good responders with 15 days a month.
  • Depression symptoms were the factor most strongly tied to disability. Acute response mattered about as much as headache frequency.
  • The study was a single-center snapshot, so it shows an association and cannot prove that better acute treatment lowers disability.
Important Medical Disclaimer

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Do not change, stop or combine migraine medicines without talking with your clinician. Seek urgent care for a sudden severe headache, a headache with weakness, confusion, fever or a stiff neck, or any headache that feels different from your usual attacks.

References

  1. Xu X, Li H, Liang X, et al. Beyond headache frequency: How acute treatment response shapes migraine-related disability-Insights from a joint stratification framework: A cross-sectional study. Headache. Published online November 2, 2026. doi:10.1111/head.70254

Guided practice

Alternate nostril breathing

A 5-minute guided practice for migraine prevention, from Unraveling Migraine. Captions are built into the video.

  • Prevention, not a rescue. Keep your usual medicine for migraine attacks.
  • Daily practice is what counts. The study behind it used 3 short sessions a day for 3 months.
  • Skip it or stop if your nose is blocked or it starts to feel like a strain.
Read the full guide and the research